Capecitabine, Oxaliplatin, Irinotecan, and Bevacizumab Combination Followed by Pazopanib Plus Capecitabine Maintenance for High-Grade Gastrointestinal Neuroendocrine Carcinomas-Reference-Cited by-同舟云学术

Capecitabine, Oxaliplatin, Irinotecan, and Bevacizumab Combination Followed by Pazopanib Plus Capecitabine Maintenance for High-Grade Gastrointestinal Neuroendocrine Carcinomas

Published:2020-01-14 Issue:5 Volume:43 Page:305-310
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Alifieris Constantinos E.,Griniatsos John,Delis Spiros G.,Nikolaou Michail,Avgoustou Constantinos,Panagiotidis Mihalis I.,Souferi-Chronopoulou Eleni,Trafalis Dimitrios T.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference35 articles.

1. A 5-decade analysis of 13715 carcinoid tumors;Modlin;Cancer,2003

2. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008

3. Current knowledge on diagnosis and staging of neuroendocrine tumors;Oberg;Cancer Metastasis Rev,2011

4. Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates;Chai;Histopathology,2018

5. Expression of vascular endothelial growth factor in digestive neuroendocrine tumours;Terris;Histopathology,1998

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer;Journal of Chemotherapy;2024-08-12

2. Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?;Endocrine Pathology;2024-03-12

3. Enhancing treatment strategies for small bowel cancer: a clinical review of targeted therapy and immunotherapy approaches;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-02-08

4. Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives;Journal of Clinical Medicine;2023-12-15

5. Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma;Cancer and Metastasis Reviews;2023-07-08